5-Fluorouracil and methotrexate combination chemotherapy: the effect of drug scheduling.

Suppr

超能文献

作者信息

Mulder J H, Smink T, van Putten L M

出版信息

Eur J Cancer Clin Oncol. 1981 Jul;17(7):831-7. doi: 10.1016/0014-2964(81)90240-1.

DOI:10.1016/0014-2964(81)90240-1

PMID:6949765

Abstract

摘要

相似文献

5-Fluorouracil and methotrexate combination chemotherapy: the effect of drug scheduling.

Eur J Cancer Clin Oncol. 1981 Jul;17(7):831-7. doi: 10.1016/0014-2964(81)90240-1.

Vincristine-methotrexate combination chemotherapy and the influence of weight loss on experimental tumour growth.长春新碱-甲氨蝶呤联合化疗及体重减轻对实验性肿瘤生长的影响。

Cancer Chemother Pharmacol. 1979;3(2):111-6. doi: 10.1007/BF00254981.

Schedule-dependent cytotoxicity of 5-fluorouracil and cyclophosphamide in experimental cancer chemotherapy.5-氟尿嘧啶和环磷酰胺在实验性癌症化疗中的时间依赖性细胞毒性。

Eur J Cancer (1965). 1980 May;16(5):699-705. doi: 10.1016/0014-2964(80)90212-1.

Adriamycin/cyclophosphamide combination chemotherapy: the importance of drug scheduling.

Eur J Cancer (1965). 1979 Dec;15(12):1503-9. doi: 10.1016/0014-2964(79)90031-8.

Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.5-氟尿嘧啶与替加氟的比较。II. 小鼠肿瘤的治疗反应及耐药性发展

Cancer Treat Rep. 1976 Sep;60(9):1347-61.

Exploratory studies of vitamin A and cyclophosphamide in tumor-bearing mice.

J Clin Pharmacol J New Drugs. 1969 Nov-Dec;9(6):359-73.

The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.

Cancer Res. 1966 May;26(5):848-52.

Schedule dependent effectiveness of CCNU and 5-fluorouracil in experimental chemotherapy.环己亚硝脲（CCNU）和5-氟尿嘧啶在实验性化疗中的时间依赖性疗效。

Eur J Cancer (1965). 1977 Oct;13(10):1123-31. doi: 10.1016/0014-2964(77)90011-1.

Lack of vincristine--cyclophosphamide potentiation in different experimental tumour lines.不同实验肿瘤细胞系中长春新碱 - 环磷酰胺不存在增效作用。

Eur J Cancer (1965). 1979 Apr;15(4):499-507. doi: 10.1016/0014-2964(79)90085-9.

Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.依托泊苷与甲氨蝶呤之间或依托泊苷、甲氨蝶呤和5-氟尿嘧啶在晚期白血病L1210中的时间和顺序依赖性协同作用。

Cancer Lett. 1985 Dec;29(3):277-82. doi: 10.1016/0304-3835(85)90137-5.

引用本文的文献

Natural Small Molecules in Gastrointestinal Tract and Associated Cancers: Molecular Insights and Targeted Therapies.胃肠道及相关癌症中的天然小分子：分子见解与靶向治疗。

Molecules. 2022 Sep 3;27(17):5686. doi: 10.3390/molecules27175686.

Tumor heterogeneity: biological implications and therapeutic consequences.肿瘤异质性：生物学意义与治疗后果

Cancer Metastasis Rev. 1983;2(1):5-23. doi: 10.1007/BF00046903.

Clinical pharmacokinetics of commonly used anticancer drugs.常用抗癌药物的临床药代动力学

Clin Pharmacokinet. 1983 May-Jun;8(3):202-32. doi: 10.2165/00003088-198308030-00002.

Sequential methotrexate (MTX) and 5-fluorouracil (FU) in human tumor xenografts.

Med Oncol Tumor Pharmacother. 1985;2(1):27-32. doi: 10.1007/BF02934777.

Lack of enhanced cytotoxicity of cultured L1210 cells using folinic acid in combination with sequential methotrexate and fluorouracil.在培养的L1210细胞中，使用亚叶酸联合序贯甲氨蝶呤和氟尿嘧啶时缺乏增强的细胞毒性。

Cancer Chemother Pharmacol. 1985;15(3):214-9. doi: 10.1007/BF00263888.

A phase II study of sequential methotrexate and 5-fluorouracil in colorectal carcinoma.

Med Oncol Tumor Pharmacother. 1988;5(4):239-41. doi: 10.1007/BF03003190.

Clinical pharmacology of 5-fluorouracil.5-氟尿嘧啶的临床药理学

Clin Pharmacokinet. 1989 Apr;16(4):215-37. doi: 10.2165/00003088-198916040-00002.

Interaction of 5'-deoxy-5-fluorouridine and methotrexate. A basis for reduced methotrexate toxicity.

Arch Toxicol. 1989;63(5):401-5. doi: 10.1007/BF00303130.

Phase I clinical and pharmacologic trial of trimetrexate in combination with 5-fluorouracil.

Cancer Chemother Pharmacol. 1989;24(2):117-22. doi: 10.1007/BF00263132.

Antineoplastic drugs in 1990. A review (Part II).1990年的抗肿瘤药物。综述（第二部分）。

Drugs. 1990 May;39(5):652-73. doi: 10.2165/00003495-199039050-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验